BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Dofetilide

dofetilide [Supplementary Concept] potassium channel antagonist that has class III activity; RN & structure given in first source

298+ PubMed studies analyzed · 43 RCTs · Evidence Score: 48.2

Research Domains

Dofetilide has been studied across 7 research domains including ❤️ Cardiovascular, 😴 Sleep, 🦴 Bone & Joint, 🧠 Focus & Attention, 🫁 Liver & Detox. The primary research focus is ❤️ Cardiovascular with 82% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Dofetilide, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Nandrolone
6 shared targets
Dexamethasone
6 shared targets
Prednisone
7 shared targets
Cyproterone
6 shared targets
Nicergoline
9 shared targets
Lactic
5 shared targets
Dydrogesterone
7 shared targets
Piribedil
7 shared targets
Ipratropium
5 shared targets
Methoxsalen
7 shared targets
Loading evidence profile...

This evidence profile for Dofetilide is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.